Cite

HARVARD Citation

    Lombardi, P. et al. (2022). New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis. Cancer treatment reviews. p. . [Online]. 
  
Back to record